CymitQuimica logo

Pramlintide

CAS:

Ref. 3D-FP156979

1g
Discontinued
2g
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .

Pramlintide
Biosynth

    Product Information

    Name:Pramlintide
    Brand:Biosynth
    Description:Pramlintide is a synthetic, short-acting insulinotropic peptide that has been shown to reduce postprandial glucagon secretion and delay gastric emptying. It also has a number of physiological effects, including the activation of ATP-sensitive potassium channels, inhibition of oxidative phosphorylation, and induction of mitochondrial membrane potential. Pramlintide is approved for use in the treatment of type 1 and type 2 diabetes mellitus. The drug binds to the glucagon receptor on pancreatic alpha cells and stimulates insulin release from beta cells in a glucose-dependent manner. Pramlintide has been shown to have no significant effect on glycemic control when used as an adjunct to insulin therapy in patients with type 2 diabetes mellitus. This drug may also cause hypoglycemia when used alone or with other antihyperglycemic agents such as sulfonylureas or meglitinides.
    Notice:Our products are intended for lab use only. For any other use, please contact us.

    Chemical properties

    Molecular weight:3,949.39 g/mol
    Formula:C171H267N51O53S2
    Purity:Min. 95%
    Color/Form:White To Off-White Solid

    Inquiry about discontinued product: Pramlintide

    ◻️
    CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
    * Mandatory fields.